Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutrophils: New Critical Regulators of Glioma
Guanyu Wang, Jinpeng Wang, Chaoshi Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22

Showing 22 citing articles:

Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis
Paweł Jarmużek, Klaudia Kozłowska, Piotr Defort, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3339-3339
Open Access | Times Cited: 38
Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression
Xuehua Kong, Yuxin Zhang, Linwei Xiang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 28
Progress of nanoparticle drug delivery system for the treatment of glioma
Guogang Lai, Hao Wu, Kaixia Yang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 6
Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas
Hui Tang, Xuping Yang, Guoqian Li, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches
Yang Yue, Wen Li, Yu Zhao, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 382-382
Open Access
Novel neutrophil targeting platforms in treating Glioblastoma: Latest evidence and therapeutic approaches
Rui Zhong, Hongmei He, X Wang
International Immunopharmacology (2025) Vol. 150, pp. 114173-114173
Closed Access
SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment
Paulina Kamińska, Peter Lund Ovesen, Mateusz Jakiel, et al.
EMBO Reports (2024) Vol. 25, Iss. 5, pp. 2278-2305
Open Access | Times Cited: 4
Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy
Landon Teer, Kavitha Yaddanapudi, Joseph Chen
Bioengineering (2024) Vol. 11, Iss. 1, pp. 93-93
Open Access | Times Cited: 2
SRPK1 Promotes Glioma Proliferation, Migration, and Invasion through Activation of Wnt/β-Catenin and JAK-2/STAT-3 Signaling Pathways
Mengna Shi, Dan Sun, Lu Deng, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 378-378
Open Access | Times Cited: 2
An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma
Εftychia Stavrakaki, Wouter van den Bossche, Lisette B. Vogelezang, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 3, pp. 100716-100716
Open Access | Times Cited: 2
Exosomal HMGB3 released by glioma cells confers the activation of NLRP3 inflammasome and pyroptosis in tumor-associated macrophages
Ping Hu, Tengfeng Yan, Shigang Lv, et al.
Tissue and Cell (2024) Vol. 88, pp. 102406-102406
Closed Access | Times Cited: 1
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Tongzheng Chen, Wenbin Ma, Xin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
SorLA restricts TNFα release from microglia to shape glioma-supportive brain microenvironment
Paulina Kamińska, Peter Lund Ovesen, Mateusz Jakiel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
A novel nomogram predicting short-term overall survival of patients with glioma
Xingjie Yang, Jian-Hua Xi, Nai-ying Sun, et al.
Research Square (Research Square) (2024)
Open Access
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy
Jiayi Wen, Dan Liu, Hongtao Zhu, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression
Juliana H. Azambuja, Saigopalakrishna S. Yerneni, Lisa M. Maurer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Efficacy and Safety of Bevacizumab Combined with Temozolomide in the Treatment of Glioma: A Systematic Review and Meta-Analysis of Clinical Trials
Chuheng Wang, Linan Duan, Yao Zhao, et al.
World Neurosurgery (2024)
Open Access
Complement C1S is a potential prognostic biomarker and associated with M2 macrophage infiltration in gliomas: From bioinformatics to comprehensive experimental validation
Lun Gao, Xuefang Jing, Qiuwei Hua, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113573-113573
Closed Access
HERV-W envelope protein is present in microglial cells of the human glioma tumor microenvironment and differentially modulates neoplastic cell behavior
Laura Reiche, Benedikt Plaack, Maren Lehmkuhl, et al.
Microbes and Infection (2024), pp. 105460-105460
Open Access
Immunotherapy against glioblastoma using backpack‐activated neutrophils
Tatsuya Fukuta, Ninad Kumbhojkar, Supriya Prakash, et al.
Bioengineering & Translational Medicine (2024) Vol. 10, Iss. 1
Open Access
Exploring the significance and potential mechanisms of hippo pathway-associated genes in prognosis of glioma patients
XuKai Liu, Hongjun Fan, Zebo Chen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
DEHP-Induced Glioblastoma in Zebrafish Is Associated with Circadian Dysregulation of PER3
Shuhui Men, Jiayun Xu, Xiao-Dong Yang, et al.
Toxics (2024) Vol. 12, Iss. 12, pp. 835-835
Open Access
Migration-inducing gene-7 promotes glioma cell proliferation and invasiveness via activating the MAPK signaling pathway
Zhigang Pan, C. Chen, Xinyue Huang, et al.
Neoplasma (2023) Vol. 70, Iss. 04, pp. 534-544
Open Access | Times Cited: 1
FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
Yifan Deng, Kailiang Zeng, Diancheng Wu, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access
Page 1

Scroll to top